World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
144
Citations
83164
World Ranking
1436
National Ranking
838

Jerry A. Shields publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jerry A. Shields sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,502 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jerry A. Shields D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jerry A. Shields sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 144 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jerry A. Shields is affiliated with Wills Eye Hospital in the United States. Their research focuses primarily on medicine, with a particular emphasis on ophthalmology and oncology. The subfields that they have contributed to include ophthalmology, oncology, pulmonary and respiratory medicine, molecular biology, and epidemiology.

The scientist's work spans several main topics such as ocular oncology and treatments, cutaneous melanoma detection and management, glaucoma and retinal disorders, brain metastases and treatment, nonmelanoma skin cancer studies, ocular infections and treatments, and vascular tumors and angiosarcomas.

Jerry A. Shields has coauthored extensively with several researchers, including Carol L. Shields, Sara E. Lally, Lauren A. Dalvin, Tatyana Milman, and Antonio Yaghy. Carol L. Shields appears as a frequent collaborator with fifty-one joint publications, followed by Sara E. Lally with twenty-four, Lauren A. Dalvin with thirteen, Tatyana Milman with twelve, and Antonio Yaghy with eleven shared works.

The researcher has published articles in a variety of scientific venues, among which the most frequent include Ophthalmology Retina, Eye, Ophthalmology, American Journal of Ophthalmology, and European Journal of Ophthalmology.

Selected recent papers reflect the scope and depth of their research:

  • Uveal melanoma, 2020, Nature Reviews Disease Primers
  • Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre, 2020, British Journal of Ophthalmology
  • Metastatic tumours to the eye. Review of metastasis to the iris, ciliary body, choroid, retina, optic disc, vitreous, and/or lens capsule, 2022, Eye
  • Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex, 2021, Journal of American Association for Pediatric Ophthalmology and Strabismus
  • An Outcome Assessment of a Single Institution's Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis, 2020, Cancers

Best Publications

  • Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.

    Jerry A Shields;Carol L Shields;Richard Scartozzi

  • Survey of 520 eyes with uveal metastases.

    Carol L. Shields;Jerry A. Shields;Nicole E. Gross;Geoffrey P. Schwartz

  • The International Classification of Retinoblastoma predicts chemoreduction success.

    Carol L. Shields;Arman Mashayekhi;Angela K. Au;Craig Czyz

  • Tumors of the conjunctiva and cornea

    Carol L Shields;Jerry A Shields

  • Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes

    Carol L. Shields;Minoru Furuta;Archana Thangappan;Saya Nagori

  • Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy.

    Wolfgang E. Lieb;Steven M. Cohen;Daniel A. Merton;Jerry A. Shields

  • Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

    Carol L. Shields;Jerry A. Shields;Kaan Gündüz;Jacqueline Cater

  • Sebaceous carcinoma of the eyelids: Personal experience with 60 cases

    Jerry A. Shields;Hakan Demirci;Brian P. Marr;Ralph C. Eagle

  • Classification and management of Coats disease: the 2000 Proctor Lecture.

    Jerry A Shields;Carol L Shields;Santosh G Honavar;Hakan Demirci

  • Chemoreduction in the Initial Management of Intraocular Retinoblastoma

    C L Shields;P De Potter;B P Himelstein;J A Shields

  • SURGICAL MANAGEMENT OF CONJUNCTIVAL TUMORS. THE 1994 LYNN B. MCMAHAN LECTURE

    J A Shields;C L Shields;P De Potter

  • Classification and incidence of space-occupying lesions of the orbit: a survey of 645 biopsies

    Jerry A. Shields;Brock Bakewell;James J. Augsburger;Joseph C. Flanagan

  • Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture

    Jerry A Shields;Carol L Shields;Sontash G Honavar;Hakan Demirci

  • Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors.

    Carol L. Shields;Hakan Demirci;Ekaterina Karatza;Jerry A. Shields

  • Sebaceous Carcinoma of the Ocular Region: A Review

    Jerry A. Shields;Hakan Demirci;Brian P. Marr;Ralph C. Eagle

  • Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture.

    Jerry A. Shields;Carol L. Shields;Heather K. Brotman;Cynthia Carvalho

  • Risk Factors for Growth and Metastasis of Small Choroidal Melanocytic Lesions

    Carol L. Shields;Jerry A. Shields;Hayyam Kiratli;Patrick De Potter

  • Congenital Pits of the Optic Nerve Head: II. Clinical Studies in Humans

    Gary C. Brown;Jerry A. Shields;Richard E. Goldberg

  • Fine-needle Aspiration Biopsy of Suspected Intraocular Tumors: The 1992 Urwick Lecture

    Jerry A. Shields;Carol L. Shields;Hormoz Ehya;Ralph C. Eagle

  • Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.

    Carol L Shields;Jerry A Shields

Frequent Co-Authors

Carol L. Shields
Carol L. Shields Thomas Jefferson University
Larry A. Donoso
Larry A. Donoso Wills Eye Hospital
Anna T. Meadows
Anna T. Meadows Children's Hospital of Philadelphia
Gary C. Brown
Gary C. Brown SUNY Upstate Medical University
Lawrence A. Yannuzzi
Lawrence A. Yannuzzi Manhattan Eye, Ear and Throat Hospital
Hans E. Grossniklaus
Hans E. Grossniklaus Emory University
Robert H. Rosenwasser
Robert H. Rosenwasser Thomas Jefferson University
Jay S. Duker
Jay S. Duker Tufts Medical Center
Carlo M. Croce
Carlo M. Croce The Ohio State University
David E. Elder
David E. Elder Hospital of the University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible or alternative pathways, online health degrees are growing in popularity. Many prospective students now consider dnp online programs to advance in nursing leadership or clinical expertise, offering convenience for working professionals.

Entry-level healthcare roles can also be accessed quickly through options like the 6 month lpn program online, designed for those who want to start their careers sooner without long, traditional routes. Specialization opportunities are also available; for instance, psychiatric care is in high demand, and pmhnp online programs help registered nurses swiftly obtain advanced credentials in mental health practice.

Diverse roles exist beyond patient care, such as healthcare management. For those budget-conscious or seeking administrative roles, analyzing healthcare administration degree cost helps prospective students make informed decisions about their educational investments. These online pathways provide valuable alternatives to traditional medical studies, supporting a variety of career aspirations in healthcare.

Best Scientists Citing Jerry A. Shields

Trending Scientists

Recently Published Articles